Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • swaraj
    Member
    • Feb 2012
    • 50

    #1

    RPKM threshold estimation

    Dear All,

    I have a doubt in the calculation of False postitive rate while checking for FPKM threshold in a RNAseq experiment.

    Following the method previously published (http://www.ploscompbiol.org/article/...l.pcbi.1000598). I am not getting desired results.

    I followed the method as mentioned the publication

    Reads were mapped to Ensembl genes (blue) and intergenic background regions (red). The intergenic regions were matched to have the same length distribution and no ESTs mapping within regions. We binned the expressions of all genes and background regions across human tissues. We zoomed in on the effects at expression spanning between 0.01 to 10 RPKM for clarity. Bins were converted to cumulative amounts of genes expressed above the expression levels for genes and controls cum_background; A false discovery rate fdr was calculated at each expression level, i, as:
    fdri=cum_backgroundi/cum_genesi * (1-cum_genesi)/(1-cum_backgroundi).

    I am confused over the fact that cum_background and cum_genes stand for the cumulative count of genes or they are the fraction of cumulative gene counts falling under each bin.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
51 views
0 reactions
Last Post SEQadmin2  
Working...